Truist downgraded Sabra Health Care REIT from Buy to Hold
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/18/2025 | $20.00 | Neutral | UBS |
| 10/1/2025 | $20.00 | Neutral | Cantor Fitzgerald |
| 1/17/2025 | Buy → Hold | Truist | |
| 1/7/2025 | $20.00 | Mkt Perform → Mkt Outperform | JMP Securities |
| 12/5/2024 | $20.00 | Outperform → Neutral | Mizuho |
| 10/1/2024 | $16.00 → $20.00 | Equal Weight → Overweight | Wells Fargo |
| 9/13/2024 | $17.00 → $20.00 | Neutral → Buy | Citigroup |
| 1/30/2024 | $21.00 | Buy | Deutsche Bank |
UBS initiated coverage of Sabra Health Care REIT with a rating of Neutral and set a new price target of $20.00
Cantor Fitzgerald initiated coverage of Sabra Health Care REIT with a rating of Neutral and set a new price target of $20.00
Truist downgraded Sabra Health Care REIT from Buy to Hold
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
10-Q - Sabra Health Care REIT, Inc. (0001492298) (Filer)
8-K - Sabra Health Care REIT, Inc. (0001492298) (Filer)
SCHEDULE 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Keefe, Bruyette & Woods, Inc., a leading specialist investment bank to the financial services and fintech sectors, and a wholly owned subsidiary of Stifel Financial Corp. (NYSE:SF), announces the upcoming index rebalancing for the fourth quarter of 2025. This quarter, there are constituent changes within six of our indexes: KBW Nasdaq Insurance Index (Index Ticker: KIX), KBW Nasdaq Regional Banking Index (Index Ticker: KRX, ETF Ticker: KBWR), KBW Nasdaq Financial Sector Dividend Yield Index (Index Ticker: KDX, ETF Ticker: KBWD), KBW Nasdaq Premium Yield Equity REIT Index (Index Ticker: KYX, ETF Ticker: KBWY), KBW Nasdaq Property and Casualty Ins
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the third quarter of 2025. THIRD QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the third quarter of 2025 were as follows: Net Income: $0.09 FFO: $0.33 Normalized FFO: $0.36 AFFO: $0.37 Normalized AFFO: $0.38 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.35x Senior Housing - Leased: 1.52x Behavioral Health, Specialty Hospitals and Other: 3.90x Same store managed senior housing Cash NOI increased 13.3% on a year-over-year basis. Excluding the 16 properties formerly operated by Holiday that remain in
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2025 third quarter earnings release on November 5, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 third quarter results will be held on Thursday, November 6th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/285294519. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland
Sabra Health Care REIT, Inc. ("Sabra") (NASDAQ:SBRA) today announced that Jessica Flores has been appointed Executive Vice President and Chief Accounting Officer and, in such capacity, has been designated by the Company's Board of Directors as the Company's principal accounting officer. Ms. Flores currently serves as Sabra's Senior Vice President – Finance and Controller, a position she has held since January 2022. Ms. Flores joined Sabra in March 2011 and held various leadership positions overseeing Sabra's accounting during that time. Ms. Flores has over 15 years of experience in accounting, finance and real estate investments, having previously worked for KBS Realty Advisors and Deloit
IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced the appointment of Katie Cusack to its Board of Directors. Ms. Cusack currently serves as Chief Operating Officer of Cornell Capital LLC, a $4 billion private investment firm with offices in New York and Hong Kong. From 2007 to 2020, Ms. Cusack served in various capacities at Credit Suisse, including Chief Operating Officer for the Investment Banking Division in both Asia Pacific and Europe, Middle East and Africa, and as the Head of Ultra-High Net Worth Coverage. Prior to joining Credit Suisse, Ms. Cusack served as a Managing Director at MTS Health Partners LP, where she provided
IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced the appointment of Ann Kono to its Board of Directors. Ms. Kono currently serves as the chief executive officer of Leda Advisory Group, a management consulting firm she founded in January 2019 that partners with startup companies to advise on growth and scale. Prior to founding Leda, Ms. Kono spent 11 years at Ares Management Corporation, where she held the position of Chief Information and Risk Officer, and oversaw Operational, Investment and Enterprise Risks. Ms. Kono also serves on the board of directors of Stable Road Acquisition Company, a position she has held since 2019. M
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Keefe, Bruyette & Woods, Inc., a leading specialist investment bank to the financial services and fintech sectors, and a wholly owned subsidiary of Stifel Financial Corp. (NYSE:SF), announces the upcoming index rebalancing for the fourth quarter of 2025. This quarter, there are constituent changes within six of our indexes: KBW Nasdaq Insurance Index (Index Ticker: KIX), KBW Nasdaq Regional Banking Index (Index Ticker: KRX, ETF Ticker: KBWR), KBW Nasdaq Financial Sector Dividend Yield Index (Index Ticker: KDX, ETF Ticker: KBWD), KBW Nasdaq Premium Yield Equity REIT Index (Index Ticker: KYX, ETF Ticker: KBWY), KBW Nasdaq Property and Casualty Ins
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the third quarter of 2025. THIRD QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the third quarter of 2025 were as follows: Net Income: $0.09 FFO: $0.33 Normalized FFO: $0.36 AFFO: $0.37 Normalized AFFO: $0.38 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.35x Senior Housing - Leased: 1.52x Behavioral Health, Specialty Hospitals and Other: 3.90x Same store managed senior housing Cash NOI increased 13.3% on a year-over-year basis. Excluding the 16 properties formerly operated by Holiday that remain in
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2025 third quarter earnings release on November 5, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 third quarter results will be held on Thursday, November 6th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/285294519. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland